From linkin We are thrilled to collaborate with Oncolytics Biotech Inc. for the evaluation of pelareorep in our forthcoming groundbreaking effort, a new master protocol for #PancreaticCancer patients!
Our planned study is designed to be more efficient and reduce the development time of testing new investigational drugs, while providing a more patient-centric approach that increases access to new potentially life-changing therapeutic options for patients with pancreatic cancer.